Acquired Company
Pfizer acquired Seagen for $229 per share in cash for a total enterprise value of approximately $43 billion, with the acquisition completed on December 14, 2023.
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. On Dec. 14, 2023, Pfizer completed the acquisition of Seagen. Show more
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$228.74
Open
$228.74
Volume
N/A
Day Range
$228.74 - $228.74
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.81%
Institutional Own.
88.83%
Qtr Updated
09/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|